Novo Nordisk A/S is conducting a share repurchase program, initiated on August 7, 2024, with an allocation of up to DKK 20 billion over 12 months, and has so far repurchased 13,597,148 B shares for a total of DKK 11.9 billion. The most recent transactions as of October 25, 2024, included purchasing 46,500 shares at an average price of DKK 801.76 each.